| The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway K Webster, J Parish, M Pandya, PL Stern, AR Clarke, K Gaston Journal of Biological Chemistry 275 (1), 87-94, 2000 | 215 | 2000 |
| ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance JL Parish, AM Bean, RB Park, EJ Androphy Molecular cell 24 (6), 867-876, 2006 | 166 | 2006 |
| The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells JL Parish, J Rosa, X Wang, JM Lahti, SJ Doxsey, EJ Androphy Journal of cell science 119 (23), 4857-4865, 2006 | 133 | 2006 |
| E2 proteins from high-and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death JL Parish, A Kowalczyk, HT Chen, GE Roeder, R Sessions, M Buckle, ... Journal of virology 80 (9), 4580-4590, 2006 | 108 | 2006 |
| Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle M Burley, S Roberts, JL Parish Seminars in immunopathology 42 (2), 159-171, 2020 | 105 | 2020 |
| Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus G Dell, KW Wilkinson, R Tranter, J Parish, RL Brady, K Gaston Journal of molecular biology 334 (5), 979-991, 2003 | 85 | 2003 |
| STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle EL Morgan, CW Wasson, L Hanson, D Kealy, I Pentland, V McGuire, ... PLoS pathogens 14 (4), e1006975, 2018 | 79 | 2018 |
| CCCTC-binding factor recruitment to the early region of the human papillomavirus 18 genome regulates viral oncogene expression C Paris, I Pentland, I Groves, DC Roberts, SJ Powis, N Coleman, ... Journal of virology 89 (9), 4770-4785, 2015 | 74 | 2015 |
| Disruption of CTCF-YY1–dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription I Pentland, K Campos-León, M Cotic, KJ Davies, CD Wood, IJ Groves, ... PLoS biology 16 (10), e2005752, 2018 | 68 | 2018 |
| The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines MB Prystowsky, A Adomako, RV Smith, N Kawachi, W McKimpson, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 64 | 2009 |
| Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan A Siddiqa, M Zainab, I Qadri, MF Bhatti, JL Parish Viruses 6 (7), 2762-2777, 2014 | 54 | 2014 |
| Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion JJM van Schie, A Faramarz, JA Balk, GS Stewart, E Cantelli, AB Oostra, ... Nature communications 11 (1), 4287, 2020 | 48 | 2020 |
| Cohesin: a regulator of genome integrity and gene expression KM Feeney, CW Wasson, JL Parish Biochemical Journal 428 (2), 147-161, 2010 | 46 | 2010 |
| Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence KM Feeney, JL Parish Proceedings of the Royal Society B: Biological Sciences 276 (1662), 1535-1544, 2009 | 45 | 2009 |
| Targeting CTCF to control virus gene expression: a common theme amongst diverse DNA viruses I Pentland, JL Parish Viruses 7 (7), 3574-3585, 2015 | 42 | 2015 |
| Human papillomavirus type 16 E2-and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia EJ Davidson, P Sehr, RL Faulkner, JL Parish, K Gaston, RA Moore, ... Journal of general virology 84 (8), 2089-2097, 2003 | 42 | 2003 |
| Modelling human papillomavirus biology in oropharyngeal keratinocytes S Roberts, D Evans, H Mehanna, JL Parish Philosophical Transactions of the Royal Society B 374 (1773), 20180289, 2019 | 41 | 2019 |
| Defining the frequency of human papillomavirus and polyomavirus infection in urothelial bladder tumours MA Llewellyn, NS Gordon, B Abbotts, ND James, MP Zeegers, KK Cheng, ... Scientific Reports 8 (1), 11290, 2018 | 39 | 2018 |
| Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck … A Kong, J Good, A Kirkham, J Savage, R Mant, L Llewellyn, J Parish, ... BMJ open 10 (3), e033009, 2020 | 38 | 2020 |
| Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck … NV Anayannis, NF Schlecht, M Ben-Dayan, RV Smith, TJ Belbin, TJ Ow, ... PloS one 13 (2), e0191581, 2018 | 37 | 2018 |
